Login / Signup

Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.

Ofir HarariMohsen SoltanifarAndre VerhoekBart Heeg
Published in: Pharmaceutical statistics (2023)
It is common practice to use hierarchical Bayesian model for the informing of a pediatric randomized controlled trial (RCT) by adult data, using a prespecified borrowing fraction parameter (BFP). This implicitly assumes that the BFP is intuitive and corresponds to the degree of similarity between the populations. Generalizing this model to any K ≥ 1 $$ K\ge 1 $$ historical studies, naturally leads to empirical Bayes meta-analysis. In this paper we calculate the Bayesian BFPs and study the factors that drive them. We prove that simultaneous mean squared error reduction relative to an uninformed model is always achievable through application of this model. Power and sample size calculations for a future RCT, designed to be informed by multiple external RCTs, are also provided. Potential applications include inference on treatment efficacy from independent trials involving either heterogeneous patient populations or different therapies from a common class.
Keyphrases
  • randomized controlled trial
  • systematic review
  • primary care
  • clinical trial
  • machine learning
  • molecular dynamics
  • climate change
  • quality improvement
  • data analysis
  • risk assessment
  • big data
  • meta analyses
  • deep learning